Comments on: Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 https://breshlynews.com/2024/10/27/biogen-presents-positive-results-from-phase-2-ignaz-study-of-felzartamab-in-iga-nephropathy-at-american-society-of-nephrology-asn-kidney-week-2024/ Fresh News At Your Fingertip Sun, 27 Oct 2024 00:54:03 +0000 hourly 1 https://wordpress.org/?v=6.8.2